[Imatinib, an inhibitor of KIT kinase activity, is now the standard front-line therapy for patients with advanced GIST.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE